Be in the know. 20 key reads for Thursday…

  1. Coty Is One of 2020’s Worst-Performing Stocks. Why an Analyst Says Its Time to Buy. (Barron’s)
  2. Chevron Is Now the Biggest U.S. Oil Stock. (Barron’s)
  3. Emerging Markets Are Looking Attractive. Strategists Are Still Wary. (Barron’s)
  4. Cruise Stocks Are Climbing After a J.P. Morgan Analyst Boosts Price Targets (Barron’s)
  5. Wynn Resorts Stock Can Double: Fund Manager (Barron’s)
  6. Regeneron seeks emergency approval for COVID-19 drug that Trump took (New York Post)
  7. Eli Lilly seeks emergency use of its antibody drug for COVID-19 (New York Post)
  8. Fleetwood Mac’s ‘Dreams’: Mick Fleetwood recreates viral, cranberry juice-swigging TikTok video (USA Today)
  9. Westchester Home Prices Pushed to Record High By Bidding Wars (Bloomberg)
  10. Trump Says Eli Lilly Drug to Be Approved And He’s Not Contagious (Bloomberg)
  11. Hydrogen’s Dirty Little Secret (Wall Street Journal)
  12. Exxon Could Get a Chemical Turbo Boost if Oil Rebounds (Wall Street Journal)
  13. Lyft Orders Up a Side Dish (Wall Street Journal)
  14. Molson Coors (TAP) PT Raised to $62 at Guggenheim, Named ‘Best Idea’ (Street Insider)
  15. Wells Fargo cuts more jobs as part of earlier cost-cutting drive (Street Insider)
  16. Trump calls contracting coronavirus ‘blessing from God’ as Regeneron files for FDA approval (MarketWatch)
  17. Can Airport Covid Testing Get People Flying Again? (Wall Street Journal)
  18. Onto a new cloud — IBM to spin off managed infrastructure services unit (MarketWatch)
  19. Bausch Health shares jump 6% premarket after company offers upbeat revenue guidance (MarketWatch)
  20. AMC Entertainment expects 520 of its 600 U.S. theaters to be open by mid-October (MarketWatch)

Be in the know. 20 key reads for Wednesday…

  1. Lilly submits authorization request to FDA for antibody-based COVID-19 therapy (MarketWatch)
  2. Boeing’s Aviation Outlook Is Surprisingly Rosy. What It Means for the Stock. (Barron’s)
  3. The Labor Department’s Latest Blow Against ESG Investing (Barron’s)
  4. Trump Pushes for $1,200 Checks, PPP, and Airline Aid After Ending Stimulus Talks (Barron’s)
  5. House Report Attacks Tech Giants as Monopolists That Stifle Competition (Barron’s)
  6. What Time Is the 2020 Vice Presidential Debate Tonight? Here When It Starts and What to Watch. (Barron’s)
  7. Donald Trump’s COVID-19 treatment is similar to the average American hospitalized with coronavirus. Only faster. (USA Today)
  8. ECB’s Lagarde Pledges No Premature Removal of Monetary Support (Bloomberg)
  9. Wells Fargo Eliminates More Than 700 Jobs in Commercial Banking (Bloomberg)
  10. The US economy can survive without new stimulus until after the election and avoid a double-dip recession, Morgan Stanley’s investment chief says (Business Insider)
  11. Molson Coors (TAP) PT Raised to $62 at Guggenheim, Named ‘Best Idea’ (Street Insider)
  12. Trump says he’d approve 2nd round of stimulus checks after halting relief talks (Fox Business)
  13. SEE IT: Bill Murray joins FBN’s ‘The Claman Countdown’ (Fox Business)
  14. How podcasting became a new front in the streaming wars (Financial Times)
  15. Bill Gates Says Regulatory Approval For Antibody Drugs Could Sharply Reduce COVID-19 Mortality (Benzinga)
  16. Real-World Evidence: The Case of Peru (TrialSiteNews)
  17. Chevron vs. Exxon: Which Is a Better Buy? (U.S. News)
  18. Global Outlook Brightens as U.S. Consumer Imports Reach Pre-Pandemic Levels (Wall Street Journal)
  19. Covid-19 Antibody Drug From Glaxo, Vir Enters Final-Stage Testing (Wall Street Journal)
  20. Hedge funds make pandemic bet on insurance (Reuters)